Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3034 |  AUTL Autolus Therapeutics plc - American Depositary Shares | 1.63 USD | +1.24% | +1.87% | +10.14% | -31.51% | 433.83 M USD | ||
| 3063 |  IPSC Century Therapeutics, Inc. - Common Stock | 2.32 USD | +0.43% | -4.53% | +8.41% | +314.29% | 418.42 M USD | ||
| 3070 |  ENTA Enanta Pharmaceuticals, Inc. - Common Stock | 14.24 USD | -0.14% | -4.94% | +26.80% | +83.03% | 414.08 M USD | ||
| 3072 |  DMAC DiaMedica Therapeutics Inc. - Common Stock | 7.67 USD | -4.01% | +4.50% | +36.23% | +108.42% | 413.29 M USD | ||
| 3082 |  PBYI Puma Biotechnology Inc - Common Stock | 8.05 USD | +1.13% | +0.25% | +15.99% | +123.61% | 409.74 M USD | ||
| 3102 |  VNDA Vanda Pharmaceuticals Inc. - Common Stock | 6.40 USD | +0.16% | +6.31% | +4.92% | +15.73% | 384.87 M USD | ||
| 3104 |  CMPX Compass Therapeutics, Inc. - Common Stock | 2.21 USD | -4.74% | +1.84% | +8.33% | -16.29% | 397.99 M USD | ||
| 3112 |  LXEO Lexeo Therapeutics, Inc. - Common Stock | 5.01 USD | +4.59% | +11.33% | +16.24% | +10.84% | 393.39 M USD | ||
| 3116 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 4.91 USD | -1.21% | -0.81% | +26.87% | +491.57% | 391.06 M USD | ||
| 3119 |  AVIR Atea Pharmaceuticals, Inc. - common stock | 4.74 USD | -2.87% | +0.42% | +8.97% | +47.66% | 379.33 M USD | ||
| 3137 |  ABEO Abeona Therapeutics Inc. - Common Stock | 6.65 USD | +1.53% | +6.57% | +23.15% | +13.68% | 379.02 M USD | ||
| 3141 |  LYEL Lyell Immunopharma, Inc. - Common Stock | 14.80 USD | -6.98% | +13.06% | +18.40% | -38.82% | 345.34 M USD | ||
| 3155 |  XFOR X4 Pharmaceuticals, Inc. - Common Stock | 3.85 USD | -2.28% | -9.62% | +3.77% | +29.63% | 363.13 M USD | ||
| 3163 |  PALI Palisade Bio, Inc. - Common Stock | 1.99 USD | -4.33% | +0.51% | +13.71% | +17.06% | 345.42 M USD | ||
| 3178 |  FHTX Foghorn Therapeutics Inc. - Common Stock | 6.46 USD | +7.67% | +29.72% | +72.27% | +58.33% | 379.29 M USD | ||
| 3179 |  EDIT Editas Medicine, Inc. - Common Stock | 3.70 USD | -1.33% | +8.50% | +40.68% | +21.31% | 362.25 M USD | ||
| 3192 |  LRMR Larimar Therapeutics, Inc. - Common Stock | 3.44 USD | +0.88% | +8.18% | +8.52% | +2.08% | 357.36 M USD | ||
| 3224 |  FENC Fennec Pharmaceuticals Inc. - Common Stock | 10.07 USD | -4.10% | -2.89% | +11.03% | +14.56% | 349.80 M USD | ||
| 3231 |  ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 4.71 USD | -1.46% | +3.52% | +31.56% | +270.87% | 335.29 M USD | ||
| 3232 |  CTNM Contineum Therapeutics, Inc. - Common stock | 15.05 USD | +3.37% | -3.71% | +28.52% | -1.44% | 347.64 M USD |
Noticias Biotechnology Stocks
BofA reitera su calificación de Beam Therapeutics tras fallo arbitral
¿Por qué cae hoy la acción de Beam Therapeutics?
¿Por qué las acciones de Prime Medicine se disparan hoy?
La acción de Incyte alcanza un máximo de 52 semanas en 118,77 dólares
Las acciones de Prime Medicine suben tras ganar arbitraje contra Beam
Resultados de Nurix Therapeutics: la atención se centra en el acuerdo con Roche
Las acciones de Edgewise Therapeutics alcanzan máximos históricos a 43,96 dólares
Gainers Biotechnology Stocks
 TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
 APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
 CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
 TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
 PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
 SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
 VANI Vivani Medical, Inc. - Common Stock | 1.50 | +11.11% |
Losers Biotechnology Stocks
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
 CCCC C4 Therapeutics, Inc. - Common Stock | 3.81 | -12.41% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
 TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |